5.46 - 5.56
4.95 - 8.28
1.7K / 2.4K (Avg.)
-276.00 | -0.02
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
12.58%
Revenue growth above 1.5x UPM.HE's 6.71%. David Dodd would confirm if the firm has a unique advantage driving sales higher.
-2.59%
Negative gross profit growth while UPM.HE is at 6.95%. Joel Greenblatt would examine cost competitiveness or demand decline.
26.46%
EBIT growth above 1.5x UPM.HE's 8.96%. David Dodd would confirm if core operations or niche positioning yield superior profitability.
26.46%
Operating income growth above 1.5x UPM.HE's 8.96%. David Dodd would confirm if consistent cost or pricing advantages drive this outperformance.
29.09%
Net income growth above 1.5x UPM.HE's 6.70%. David Dodd would check if a unique moat or cost structure secures superior bottom-line gains.
-25.81%
Negative EPS growth while UPM.HE is at 7.14%. Joel Greenblatt would expect urgent managerial action on costs or revenue drivers.
-25.81%
Negative diluted EPS growth while UPM.HE is at 7.14%. Joel Greenblatt would require immediate efforts to restrain share issuance or boost net income.
-0.69%
Both firms reduce share counts. Martin Whitman would compare buyback intensity relative to free cash flow generation.
-0.69%
Reduced diluted shares while UPM.HE is at 0.00%. Joel Greenblatt would see a relative advantage if the competitor is diluting more.
No Data
No Data available this quarter, please select a different quarter.
697.62%
OCF growth above 1.5x UPM.HE's 41.94%. David Dodd would confirm a clear edge in underlying cash generation.
524.12%
Positive FCF growth while UPM.HE is negative. John Neff would see a strong competitive edge in net cash generation.
-17.22%
Both companies have negative long-term revenue/share growth. Martin Whitman would question if the entire market or product set is shrinking.
43.94%
Positive 5Y CAGR while UPM.HE is negative. John Neff might see an underappreciated edge for the firm vs. the competitor.
5.72%
Positive 3Y CAGR while UPM.HE is negative. John Neff might view this as a sharp short-term edge or successful pivot strategy.
674.87%
10Y OCF/share CAGR above 1.5x UPM.HE's 7.25%. David Dodd would check if a superior product mix or cost edge drives this outperformance.
761.09%
Positive OCF/share growth while UPM.HE is negative. John Neff might see a comparative advantage in operational cash viability.
264.22%
Positive 3Y OCF/share CAGR while UPM.HE is negative. John Neff might see a big short-term edge in operational efficiency.
235.29%
Positive 10Y CAGR while UPM.HE is negative. John Neff might see a substantial advantage in bottom-line trajectory.
283.33%
5Y net income/share CAGR above 1.5x UPM.HE's 21.36%. David Dodd would confirm if the firm’s strategy is more effective in generating mid-term profits.
91.67%
Positive short-term CAGR while UPM.HE is negative. John Neff would see a clear advantage in near-term profit trajectory.
59.17%
10Y equity/share CAGR above 1.5x UPM.HE's 27.63%. David Dodd would confirm if consistent earnings retention or fewer write-downs drive this advantage.
69.86%
5Y equity/share CAGR above 1.5x UPM.HE's 22.76%. David Dodd might see stronger earnings retention or fewer asset impairments fueling growth.
29.41%
3Y equity/share CAGR above 1.5x UPM.HE's 7.68%. David Dodd verifies the company’s short-term capital management far exceeds the competitor’s pace.
No Data
No Data available this quarter, please select a different quarter.
67.55%
Similar 5Y dividend/share CAGR to UPM.HE's 73.31%. Walter Schloss sees parallel philosophies in mid-term capital returns.
22.04%
3Y dividend/share CAGR above 1.5x UPM.HE's 13.05%. David Dodd sees a superior short-term capital return strategy if supported by stable earnings.
8.76%
AR growth well above UPM.HE's 8.96%. Michael Burry fears inflated revenue or higher default risk in the near future.
-5.91%
Inventory is declining while UPM.HE stands at 1.81%. Joel Greenblatt sees potential cost and margin benefits if sales hold up.
2.40%
Positive asset growth while UPM.HE is shrinking. John Neff sees potential for us to outgrow the competitor if returns are solid.
7.30%
BV/share growth above 1.5x UPM.HE's 3.29%. David Dodd confirms if consistent profit retention or fewer write-downs yield faster equity creation.
-2.48%
Both reduce debt yoy. Martin Whitman sees a broader sector shift to safer balance sheets or less growth impetus.
No Data
No Data available this quarter, please select a different quarter.
-8.39%
We cut SG&A while UPM.HE invests at 0.00%. Joel Greenblatt sees a short-term margin benefit but wonders if the competitor invests for future gains.